|
1
|
Yang M, Wang M, Li X, Xie Y, Xia X, Tian
J, Zhang K and Tang A: Wnt signaling in cervical cancer? J Cancer.
9:1277–1286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crosbie EJ, Einstein MH, Franceschi S and
Kitchener HC: Human papillomavirus and cervical cancer. Lancet.
382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shelley C, Gore M, Tan S, Thomas K and
Eeles R: Cervical spine fractures in patients undergoing palliative
radiotherapy to the cervical spine: Iimplications for Practice.
Clin Oncol (R Coll Radiol). Apr 10–2018.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Isono-Nakata R, Tsubamoto H, Ueda T, Inoue
K and Shibahara H: Bevacizumab with metronomic chemotherapy of
low-dose oral cyclophosphamide in recurrent cervical cancer: Four
cases. Gynecol Oncol Rep. 24:57–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sevin BU, Nadji M, Lampe B, Lu Y,
Hilsenbeck S, Koechli OR and Averette HE: Prognostic factors of
early stage cervical cancer treated by radical hysterectomy.
Cancer. 76 10 Suppl:S1978–S1986. 1995. View Article : Google Scholar
|
|
7
|
Einstein MH, Park KJ, Sonoda Y, Carter J,
Chi DS, Barakat RR and Abu-Rustum NR: Radical vaginal versus
abdominal trachelectomy for stage IB1 cervical cancer: A comparison
of surgical and pathologic outcomes. Gynecol Oncol. 112:73–77.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Plante M, Gregoire J, Renaud MC and Roy M:
The vaginal radical trachelectomy: An update of a series of 125
cases and 106 pregnancies. Gynecol Oncol. 121:290–297. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim CH, Abu-Rustum NR, Chi DS, Gardner GJ,
Leitao MJ Jr, Carter J, Barakat RR and Sonoda Y: Reproductive
outcomes of patients undergoing radical trachelectomy for
early-stage cervical cancer. Gynecol Oncol. 125:585–588. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bentivegna E, Gouy S, Maulard A, Chargari
C, Leary A and Morice P: Oncological outcomes after
fertility-sparing surgery for cervical cancer: A systematic review.
Lancet Oncol. 17:e240–e253. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baiocchi G, de Brot L, Faloppa CC, Mantoan
H, Duque MR, Badiglian-Filho L, Da CA and Kumagai LY: Is
parametrectomy always necessary in early-stage cervical cancer?
Gynecol Oncol. 146:16–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Yao T, Lin Z and Gao Y: Aberrant
methylation of MEG3 functions as a potential Plasma-based biomarker
for cervical cancer. Sci Rep. 7:62712017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen AH, Qin YE, Tang WF, Tao J, Song HM
and Zuo M: MiR-34a and miR-206 act as novel prognostic and therapy
biomarkers in cervical cancer. Cancer Cell Int. 17:632017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noordhuis MG, Fehrmann RS, Wisman GB,
Nijhuis ER, van Zanden JJ, Moerland PD, Ver Loren van Themaat E,
Volders HH, Kok M, Ten Hoor KA, et al: Involvement of the TGF-beta
and beta-catenin pathways in pelvic lymph node metastasis in
early-stage cervical cancer. Clin Cancer Res. 17:1317–1330. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. Bmc
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeng H, Chen W, Zheng R, Zhang S, Ji JS,
Zou X, Xia C, Sun K, Yang Z, Li H, et al: Changing cancer survival
in China during 2003–15: A pooled analysis of 17 population-based
cancer registries. Lancet Glob Health. 6:e555–e567. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen JG, Chen HZ, Zhu J, Yang YL, Zhang
YH, Huang PX, Chen YS, Zhu CY, Yang LP, Shen K, et al: Cancer
survival in patients from a hospital-based cancer registry, China.
J Cancer. 9:851–860. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shu T, Zhao D, Li B, Wang Y, Liu S, Li P,
Zuo J, Bai P, Zhang R and Wu L: Prognostic evaluation of
postoperative adjuvant therapy for operable cervical cancer: 10
years' experience of national cancer center in China. Chin J Cancer
Res. 29:510–520. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cardoso MFS, Castelletti CHM, Lima-Filho
JL, Martins DBG and Teixeira JAC: Putative biomarkers for cervical
cancer: SNVs, methylation and expression profiles. Mutat Res.
773:161–173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei LC, Li X, Zhang Y, Dang YZ, Li WW, Li
JP, Zhao LN, Liu SJ, Li X and Shi M: Individualized pelvic
lymphadenectomy should follow neoadjuvant concurrent
chemoradiotherapy for locally advanced cervical cancer. Medicine
(Baltimore). 97:e03312018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li F, Guo H, Qiu H, Liu S, Wang K, Yang C,
Tang C, Zheng Q and Hou Y: Urological complications after radical
hysterectomy with postoperative radiotherapy and radiotherapy alone
for cervical cancer. Medicine (Baltimore). 97:e01732018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Kong W, Lv N, Li F, Chen J, Jiao
S, Ding D, Zhao H and Song D: Incidence of radiation enteritis in
cervical cancer patients treated with definitive radiotherapy
versus adjuvant radiotherapy. J Cancer Res Ther. 14
Suppl:S120–S124. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang S, Xing L, Gu L, Cheng H, Feng Y and
Zhang Y: Combination of RIZ1 overexpression and radiotherapy
contributes to apoptosis and DNA damage of HeLa and SiHa cervical
cancer cells. Basic Clin Pharmacol Toxicol. Mar 25–2018.(Epub ahead
of print). View Article : Google Scholar
|
|
25
|
Moelle U, Mathewos A, Aynalem A,
Wondemagegnehu T, Yonas B, Begoihn M, Addissie A, Unverzagt S,
Jemal A, Thomssen C, et al: Cervical cancer in Ethiopia: The effect
of adherence to radiotherapy on survival. Oncologist. Mar
22–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsin MC, Hsieh YH, Wang PH, Ko JL, Hsin IL
and Yang SF: Hispolon suppresses metastasis via autophagic
degradation of cathepsin S in cervical cancer cells. Cell Death
Dis. 8:e30892017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhuang K, Yan Y, Zhang X, Zhang J, Zhang L
and Han K: Gastrin promotes the metastasis of gastric carcinoma
through the β-catenin/TCF-4 pathway. Oncol Rep. 36:1369–1376. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen HC, Huang HY, Chen YL, Lee KD, Chu
YR, Lin PY, Hsu CC, Chu PY, Huang TH, Hsiao SH and Leu YW:
Methylation of the tumor suppressor genes HIC1 and RassF1A clusters
independently from the methylation of polycomb target genes in
colon cancer. Ann Surg Oncol. 24:578–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sako A, Kitayama J, Yamaguchi H, Kaisaki
S, Suzuki H, Fukatsu K, Fujii S and Nagawa H: Vascular endothelial
growth factor synthesis by human omental mesothelial cells is
augmented by fibroblast growth factor-2: Possible role of
mesothelial cell on the development of peritoneal metastasis. J
Surg Res. 115:113–120. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Q, Zhang F and Hong Y: Blocking of
autocrine IGF-1 reduces viability of human umbilical cord
mesenchymal stem cells via inhibition of the Akt/Gsk-3β signaling
pathway. Mol Med Rep. 17:4681–4687. 2018.PubMed/NCBI
|
|
31
|
Merikhian P, Ghadirian R, Farahmand L,
Mansouri S and Majidzadeh AK: MUC1 induces tamoxifen resistance in
estrogen receptor-positive breast cancer. Expert Rev Anticancer
Ther. 17:607–613. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ye Q, Yan Z, Liao X, Li Y, Yang J, Sun J,
Kawano T, Wang X, Cao Z, Wang Z and Huang L: MUC1 induces
metastasis in esophageal squamous cell carcinoma by upregulating
matrix metalloproteinase 13. Lab Invest. 91:778–787. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Morse EM, Sun X, Olberding JR, Ha BH,
Boggon TJ and Calderwood DA: PAK6 targets to cell-cell adhesions
through its N-terminus in a Cdc42-dependent manner to drive
epithelial colony escape. J Cell Sci. 129:380–393. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang M, Siedow M, Saia G and Chakravarti
A: Inhibition of p21-activated kinase 6 (PAK6) increases
radiosensitivity of prostate cancer cells. Prostate. 70:807–816.
2010.PubMed/NCBI
|
|
35
|
Fang ZP, Jiang BG, Gu XF, Zhao B, Ge RL
and Zhang FB: P21-activated kinase 5 plays essential roles in the
proliferation and tumorigenicity of human hepatocellular carcinoma.
Acta Pharmacol Sin. 35:82–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu W, Liu Y, Liu H, Zhang W, Fu Q, Xu J
and Gu J: Tumor suppressive function of p21-activated kinase 6 in
hepatocellular carcinoma. J Biol Chem. 290:28489–28501. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Meng W, Xue S and Chen Y: The role of
CXCL12 in tumor microenvironment. Gene. 641:105–110. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Goffart N, Lombard A, Lallemand F, Kroonen
J, Nassen J, Di Valentin E, Berendsen S, Dedobbeleer M, Willems E,
Robe P, et al: CXCL12 mediates glioblastoma resistance to
radiotherapy in the subventricular zone. Neuro Oncol. 19:66–77.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Collins PJ, McCully ML, Martinez-Muñoz L,
Santiago C, Wheeldon J, Caucheteux S, Thelen S, Cecchinato V,
Laufer JM, Purvanov V, et al: Epithelial chemokine CXCL14
synergizes with CXCL12 via allosteric modulation of CXCR4. FASEB J.
31:3084–3097. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chang S, Li Y, Yuan F, Qu M, Song Y, Zhang
Z, Yang GY and Wang Y: Monomeric CXCL12 outperforms its dimeric and
wild type variants in the promotion of human endothelial progenitor
cells' function. Biochem Biophys Res Commun. 488:303–310. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
LIFR functions as a metastasis suppressor
in hepatocellular carcinoma by negatively regulating
phosphoinositide 3-kinase/AKT pathway. Carcinogenesis.
36:1201–1212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma D, Jing X, Shen B, Liu X, Cheng X, Wang
B, Fu Z, Peng C and Qiu W: Leukemia inhibitory factor receptor
negatively regulates the metastasis of pancreatic cancer cells
in vitro and in vivo. Oncol Rep. 36:827–836. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu Y, Jin Y, Liu L, Zhang X, Chen Y and
Wei J: Study of circulating IgG antibodies to peptide antigens
derived from BIRC5 and MYC in cervical cancer. FEBS Open Bio.
5:198–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pan X, Karner CM and Carroll TJ: Myc
cooperates with beta-catenin to drive gene expression in nephron
progenitor cells. Development. 144:4173–4182. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qiu S, Liu PY and Liu T: Up-regulation of
LYAR blocks Myc-induced cell death. Cell Cycle. 16:1857–1858. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lee JE, Rayyan M, Liao A, Edery I and
Pletcher SD: Acute dietary restriction acts via TOR, PP2A, and Myc
signaling to boost innate immunity in drosophila. Cell Rep.
20:479–490. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim EY, Kim A, Kim SK and Chang YS: MYC
expression correlates with PD-L1 expression in non-small cell lung
cancer. Lung Cancer. 110:63–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang X, Zhang D, Sjölinder M, Wan Y and
Sjölinder H: CD46 accelerates macrophage-mediated host
susceptibility to meningococcal sepsis in a murine model. Eur J
Immunol. 47:119–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
